Pharma Blog Watch

Access to Experimental Drugs (Eye on FDA)
In his blog, Mark Senak discusses the ways in which the FDA has worked to make important drugs available faster, such as through priority review and accelerated approval, and most recently through a proposed rule to make experimental drugs more available to seriously ill patients.

"The next step is for the FDA to be packaging these kinds of positive steps and announcements into a coherent plan that works to restore public confidence in the agency. As a stand alone milestone, it is great, but don't expect people to connect the dots and believe that the agency has turned a corner. That takes a plan."